Most Recent Articles by Tara Haelle
Although regarded as a miracle drug to some, nusinersen comes with some troublesome strings attached.
Surgical interventions for Parkinson disease are experiencing a swell in innovation, thanks in part to the entry of two additional medical device companies into a field previously dominated by one company.
Although compensating for their difficulties may help people with ASD connect with others, get jobs, and successfully navigate social situations, accumulating research suggests it can also lead to exhaustion, burnout, anxiety, and depression.
Although deep brain stimulation, similar to all Parkinson disease therapies, cannot cure, modify, or slow progression of the disease, some recent research suggests that the symptom alleviation and quality-of-life improvement it provides might lead to mild improvements in longevity.
Patients with hepatitis C were 29% more likely to develop Parkinson's after accounting for age, sex and other health conditions.
Neurology Advisor Articles
- Survival in Parkinson Disease Dependent on Parkinsonian Type, Characteristics
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Mobile Health Apps for Headache: An Ongoing Search for Clinical Relevancy
- Behavioral Therapies May Treat Headache and Post-Concussive Symptoms
- CBD Superior to Placebo, Similar to AEDs for Managing Epilepsy Syndromes
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Hematology Indicates Need for Thrombophilia Test in Children With Migraines
- Increased Stroke Risk Following Surgical vs Transfemoral Aortic Valve Replacement
- Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
- Cerebellar Stimulation May Help Improve Gait and Balance Recovery in Stroke
- Increased Dementia Risk in Older Adults With Down Syndrome
- Psychotherapy May Reduce Frequency of Nonepileptic Seizures
- Should CHA2DS2-VASc Be Reassessed More Frequently to Improve Stroke Prevention in Afib?